NCT02761057 2025-01-13Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has ProgressedNational Cancer Institute (NCI)Phase 2 Completed152 enrolled 19 charts
NCT01979536 2024-04-30Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell LymphomaNational Cancer Institute (NCI)Phase 2 Completed137 enrolled 13 charts